Equity Capital Markets

Company · CIK 1139685

20/20 Biolabs, Inc.

CIK1139685 (SEC EDGAR)
Industry (SIC)8734 — Services-Testing Laboratories
Incorporated inDE
Business addressMD
ListedAIDX (Nasdaq)
First annual or quarterly report2026-03-31

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-294903
Registered companyEffective
 2026-04-062026-04-102
333-292125
First-time registrationEffective
 2025-12-122026-04-095

Filings

9
FiledFilingRegistrationAccession
2026-04-10EFFECTDeclared effective 333-2949039999999995-26-001159
2026-04-09EFFECTDeclared effective 333-2921259999999995-26-001126
2026-04-06S-1Registration filed 333-2949030001213900-26-040553
2026-02-17EFFECTDeclared effective 333-2921259999999995-26-000603
2026-01-26S-1/AAmendment 333-2921250001213900-26-007650
2026-01-21S-1/AAmendment 333-2921250001213900-26-006263
2025-12-12S-1Registration filed 333-2921250001213900-25-121285
2025-07-17DRSDraft made public 377-082200001213900-25-065183
2023-05-15DRSDraft made public 377-067180001213900-23-039922

All filings of this company · CSV